Circe Biomedical Overview

  • Founded
  • 1996
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 25
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $26M
Latest Deal Amount

Circe Biomedical General Information

Description

Developer of bioartificial organs from isolated mammalian cells and membranes for patients suffering from acute, end-stage liver failure. The company's product HepatAssist® Liver Support System integrates viable liver cells with biocompatible membranes into an extracorporeal, bioartificial liver assist system.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Other Industries
Surgical Devices
Biotechnology
Primary Office
  • 99 Hayden Avenue
  • Lexington, MA 02421
  • United States
+1 (781) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Circe Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 11-Mar-2002 $26M 000.00 0000 Completed Product Development
2. Later Stage VC (Series C) 18-Dec-2000 0000 000.00 00000 Completed Product Development
1. Early Stage VC 07-Apr-1999 $16.4M $16.4M 000.00 Completed Product Development
To view Circe Biomedical’s complete valuation and funding history, request access »

Circe Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00 00 00 00 000
Series B 00,000,000 00.000000 00 00 00 000
Series A 799,920 $0.010000 $0.5 $0.5 1x $0.5 1.6%
To view Circe Biomedical’s complete cap table history, request access »

Circe Biomedical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Circe Biomedical Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Advanced Technology Ventures Venture Capital Minority 000 0000 000000 0
Asahi Chemical Corporation Minority 000 0000 000000 0
BancBoston Ventures Venture Capital Minority 000 0000 000000 0
Bessemer Venture Partners Venture Capital Minority 000 0000 000000 0
Burrill & Co Merchant Banking Firm Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »